MyGENESIS-PATH: Digital Program for Donor-Conceived People
MyGENESIS-Path
A Randomized Pilot and Feasibility Trial of a Digital Psychoeducational Intervention for Donor-Conceived Adults (MyGENESIS-PATH)
1 other identifier
interventional
60
1 country
1
Brief Summary
MyGENESIS-PATH is a self-guided digital psychoeducational intervention designed to support donor-conceived adults in navigating donor-conception-related information and uncertainty, DNA testing, identity, family relationships, disclosure, stigma, and expectations concerning donors and donor siblings. This two-arm randomized pilot and feasibility trial will evaluate the feasibility and acceptability of delivering MyGENESIS-PATH and of conducting a future definitive randomized controlled trial. Sixty donor-conceived adults will be randomly allocated in a 1:1 ratio to immediate access to MyGENESIS-PATH or to a waitlist control condition. Primary feasibility outcomes will assess recruitment, completion of the 4-week follow-up assessment, completeness of psychosocial outcome data, intervention uptake and completion, and completion of the immediate post-intervention feedback assessment. Intervention acceptability, usability, perceived usefulness, relevance, emotional manageability, and potential unwanted effects will be assessed among participants allocated to MyGENESIS-PATH. Changes in perceived stress, psychological well-being, coping, and donor-conception-related identity from baseline to 4 weeks after randomization will be examined as exploratory outcomes. The study is not powered to detect definitive intervention effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 17, 2026
CompletedFirst Posted
Study publicly available on registry
March 9, 2026
CompletedStudy Start
First participant enrolled
August 18, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2026
Study Completion
Last participant's last visit for all outcomes
November 30, 2026
July 17, 2026
July 1, 2026
2 months
February 17, 2026
July 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Recruitment feasibility
Number of eligible participants who provide informed consent, complete the baseline questionnaire, and are randomized during the planned recruitment period. The recruitment target is 60 randomized participants within the planned recruitment period. The number screened, number eligible, number consenting, number completing baseline, and mean number randomized per month will also be reported.
From recruitment opening to completion of recruitment, anticipated to be approximately 3 months
Acceptability of MyGENESIS-PATH
Acceptability will be assessed immediately after intervention completion among participants allocated to MyGENESIS-PATH using participant ratings of perceived usefulness; perceived relevance; emotional manageability; willingness to recommend the intervention to another donor-conceived person. Acceptability will also be explored qualitatively through optional open-ended feedback.
Immediately after completing the intervention.
Completion of the 4-week follow-up assessment
Percentage of all randomized participants who submit the 4-week follow-up questionnaire. The numerator will be the number of randomized participants submitting the follow-up questionnaire, and the denominator will be all randomized participants. A completion rate of at least 80% will support progression without major modification.
4 weeks after randomization
Secondary Outcomes (3)
Psychological well-being
Baseline (pre-intervention) and 4 weeks post-randomization
Coping
Baseline (pre-intervention) and 4 weeks post-randomization
Donor-conception identity
Baseline (pre-intervention) and 4 weeks post-randomization
Study Arms (2)
MyGENESIS Intervention
EXPERIMENTALParticipants randomized to this arm receive access to the MyGENESIS digital psychoeducational program, consisting of five sequential self-guided online modules.
Waitlist Control Group
NO INTERVENTIONParticipants in this arm do not receive access to the MyGENESIS intervention during the study period and are offered access after completion of post-test assessments.
Interventions
A self-guided digital psychoeducational intervention based on cognitive-behavioral principles and the transactional model of stress.
Eligibility Criteria
You may qualify if:
- Donor-conceived people
- Aged 18 or over
- Able to read and understand English
- Provide informed consent
You may not qualify if:
- Previous participation in the MyGENESIS-PATH alpha-testing phase
- Unable to provide informed consent
- Unable to complete the online study procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidade do Portolead
- Fundação para a Ciência e a Tecnologiacollaborator
Study Sites (1)
Faculty of Psychology and Education Sciences, University of Porto
Porto, Porto District, 4200, Portugal
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- This is an open-label study. Participants will know whether they have immediate access to MyGENESIS-PATH. The research team will also have access to group allocation where required for intervention administration and follow-up. Outcomes will be assessed using self-administered online questionnaires. No blinded outcome assessor is involved.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 17, 2026
First Posted
March 9, 2026
Study Start (Estimated)
August 18, 2026
Primary Completion (Estimated)
October 31, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
July 17, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will share
De-identified individual participant data and supporting documentation (study protocol, statistical analysis plan, and informed consent form template) will be made available upon reasonable request to the principal investigator following publication of the primary results. Requests will be reviewed by the research team and will require a data sharing agreement and confirmation of ethical approval where applicable.